DE1146495B - Verfahren zur Herstellung von Tri-[ª‰-theophyllinyl-(7)-aethyl]-orthophosphorsaeureester - Google Patents
Verfahren zur Herstellung von Tri-[ª‰-theophyllinyl-(7)-aethyl]-orthophosphorsaeureesterInfo
- Publication number
- DE1146495B DE1146495B DEH39159A DEH0039159A DE1146495B DE 1146495 B DE1146495 B DE 1146495B DE H39159 A DEH39159 A DE H39159A DE H0039159 A DEH0039159 A DE H0039159A DE 1146495 B DE1146495 B DE 1146495B
- Authority
- DE
- Germany
- Prior art keywords
- orthophosphoric acid
- tri
- acid ester
- theophyllinyl
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title claims description 10
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
- 235000011007 phosphoric acid Nutrition 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 2
- 239000006096 absorbing agent Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 4
- 229960005387 etofylline Drugs 0.000 description 4
- 229960000278 theophylline Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NWPRCRWQMGIBOT-UHFFFAOYSA-N 7-(2-hydroxyethyl)-1,3-dimethylpurine-2,6-dione Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CCO)C=N2 NWPRCRWQMGIBOT-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- -1 orthophosphoric acid ester Chemical class 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR792055A FR1343459A (fr) | 1959-04-14 | 1959-04-14 | Dérivés de la théophylline et leur préparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1146495B true DE1146495B (de) | 1963-04-04 |
Family
ID=8713632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEH39159A Pending DE1146495B (de) | 1959-04-14 | 1960-04-13 | Verfahren zur Herstellung von Tri-[ª‰-theophyllinyl-(7)-aethyl]-orthophosphorsaeureester |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE1146495B (fr) |
| FR (1) | FR1343459A (fr) |
| LU (1) | LU38510A1 (fr) |
| NL (2) | NL121068C (fr) |
-
0
- NL NL250531D patent/NL250531A/xx unknown
- LU LU38510D patent/LU38510A1/xx unknown
- NL NL121068D patent/NL121068C/xx active
-
1959
- 1959-04-14 FR FR792055A patent/FR1343459A/fr not_active Expired
-
1960
- 1960-04-13 DE DEH39159A patent/DE1146495B/de active Pending
Non-Patent Citations (1)
| Title |
|---|
| None * |
Also Published As
| Publication number | Publication date |
|---|---|
| LU38510A1 (fr) | |
| FR1343459A (fr) | 1963-11-22 |
| NL121068C (fr) | |
| NL250531A (fr) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT395853B (de) | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung | |
| DE68912263T2 (de) | 4-Methyl-5[2-(4-phenyl-1-piperazinyl)-ethyl]-Thiazolderivate, ihre Herstellung und Zusammenstellungen, die sie enthalten. | |
| CH632759A5 (de) | Verfahren zur herstellung neuer substituierter purine. | |
| DE2702092A1 (de) | Chroman-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
| EP0521353B1 (fr) | Medicament antinéoplastique contenant du octadécyl-[2-(N-méthyl pipéridino)-éthyl] phosphate, et synthèse du même | |
| DE1146495B (de) | Verfahren zur Herstellung von Tri-[ª‰-theophyllinyl-(7)-aethyl]-orthophosphorsaeureester | |
| DE2403786A1 (de) | Neue derivate der cumarine | |
| DE1242619B (de) | Verfahren zur Herstellung von neuen Nikotionsaeureestern | |
| CH497413A (de) | Verfahren zur Herstellung von Acylderivaten des Proscillaridins A | |
| DE1817861C3 (de) | N-alkylierte 3,4-Methylendioxymandelsäureamidine und deren pharmakologisch nicht giftige Säureanlagerungssalze und diese enthaltende pharmazeutische Mittel. Ausscheidung aus: 1811804 | |
| DE2159679C3 (de) | Isonipecotinsäurederivate | |
| AT343139B (de) | Verfahren zur herstellung neuer phosphinyl-derivate | |
| AT288390B (de) | Verfahren zur Herstellung eines neuen Zimtsäureamids | |
| AT277474B (de) | Verfahren zur Herstellung neuer Derivate von Bufadienolidglykosiden | |
| AT251585B (de) | Verfahren zur Herstellung von neuen 6,7-Dihydro-5H-pyrrolo-[3,4-d]-pyrimidinen | |
| AT280263B (de) | Verfahren zur herstellung von neuen furazanderivaten | |
| AT329022B (de) | Verfahren zur herstellung von neuen halogenierten hydroxybenzylaminen sowie deren saureadditionssalzen | |
| AT288395B (de) | Verfahren zur Herstellung von neuen Zimtsäureamiden | |
| DE2016057C3 (de) | Eckige Klammer auf (Thenyliden (2)- amino)-oxy] -alkylcarbonsäuren, deren Salze und Alkylester, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| AT371440B (de) | Verfahren zur herstellung von neuen n-substituierten moranolinderivaten und ihrer saeureadditionssalze | |
| DE1944758C3 (de) | 1 -Cinnamoyl^-methyl-S-methoxy-Sindolylessigsäureester, Verfahren zu ihrer Herstellung und Arzneipräparate | |
| AT288398B (de) | Verfahren zur Herstellung von neuen Zimtsäureamiden | |
| AT334885B (de) | Verfahren zur herstellung von neuen basischen estern oder amiden der 3,5-dimethylbenzoesaure und deren salzen | |
| AT230372B (de) | Verfahren zur Herstellung von neuen 4-Amino-1-phenyl-2,3-dimethyl-pyrazolon-Derivaten | |
| AT281822B (de) | Verfahren zur Herstellung neuer Zimtsäureamide |